Healthcare provider profile · identity verified

Marilynn W Moore, MD

Internal Medicine · PASADENA, CA · NPI 1306824545

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	828	83
Amlodipine Besylate	Amlodipine Besylate	581	90
Atorvastatin Calcium	Atorvastatin Calcium	462	84
Rosuvastatin Calcium	Rosuvastatin Calcium	327	34
Quetiapine Fumarate	Quetiapine Fumarate	323	37
Gabapentin	Gabapentin	284	45
Mirtazapine	Mirtazapine	256	35
Furosemide	Furosemide	249	43
Eliquis	Apixaban	236	29
Lisinopril	Lisinopril	234	29
Potassium Chloride	Potassium Chloride	233	44
Famotidine	Famotidine	230	31
Losartan Potassium	Losartan Potassium	207	34
Trazodone Hcl	Trazodone Hcl	189	27
Tamsulosin Hcl	Tamsulosin Hcl	186	26
Pantoprazole Sodium	Pantoprazole Sodium	184	35
Omeprazole	Omeprazole	179	35
Tramadol Hcl	Tramadol Hcl	175	49
Sertraline Hcl	Sertraline Hcl	165	29
Metformin Hcl	Metformin Hcl	153	30
Metoprolol Tartrate	Metoprolol Tartrate	129	17
Memantine Hcl	Memantine Hcl	124	14
Escitalopram Oxalate	Escitalopram Oxalate	123	18
Lorazepam	Lorazepam	122	28
Donepezil Hcl Odt	Donepezil Hcl	112	11
Metoprolol Succinate	Metoprolol Succinate	108	21
Amiodarone Hcl	Amiodarone Hcl	99	13
Divalproex Sodium	Divalproex Sodium	91	11
Quetiapine Fumarate Er	Quetiapine Fumarate	89	suppressed
Methenamine Hippurate	Methenamine Hippurate	84	12
Donepezil Hcl	Donepezil Hcl	81	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	81	17
Alendronate Sodium	Alendronate Sodium	80	suppressed
Dexlansoprazole Dr	Dexlansoprazole	76	suppressed
Levetiracetam	Levetiracetam	75	12
Simvastatin	Simvastatin	71	13
Metformin Er Gastric	Metformin Hcl	67	suppressed
Duloxetine Hcl	Duloxetine Hcl	64	suppressed
Valsartan	Valsartan	64	suppressed
Citalopram Hbr	Citalopram Hydrobromide	63	suppressed
Memantine Hcl Er	Memantine Hcl	63	suppressed
Synthroid	Levothyroxine Sodium	63	12
Hydrochlorothiazide	Hydrochlorothiazide	61	13
Azithromycin	Azithromycin	59	45
Alprazolam	Alprazolam	55	17
Carvedilol	Carvedilol	52	suppressed
Hydralazine Hcl	Hydralazine Hcl	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	suppressed
Enalapril Maleate	Enalapril Maleate	49	suppressed
Albuterol Sulfate	Albuterol Sulfate	47	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	11
Myrbetriq	Mirabegron	41	suppressed
Mometasone Furoate	Mometasone Furoate	38	12
Methocarbamol	Methocarbamol	37	suppressed
Sodium Chloride	Sodium Chloride 0.45 %	37	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	20
Doxycycline Hyclate	Doxycycline Hyclate	36	24
Allopurinol	Allopurinol	35	suppressed
Atenolol	Atenolol	35	suppressed
Cephalexin	Cephalexin	34	29
Hydrocortisone	Hydrocortisone	34	14
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Klor-Con 10	Potassium Chloride	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	11
Ondansetron Hcl	Ondansetron Hcl	29	14
Ezetimibe	Ezetimibe	27	suppressed
Lidocaine	Lidocaine	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	23
Digoxin	Digoxin	26	suppressed
Cyclosporine	Cyclosporine	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Loperamide	Loperamide Hcl	25	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	24	suppressed
Finasteride	Finasteride	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	24	suppressed
Risperidone Odt	Risperidone	24	suppressed
Baclofen	Baclofen	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Linzess	Linaclotide	23	suppressed
Lithium Carbonate	Lithium Carbonate	23	suppressed
Olanzapine Odt	Olanzapine	23	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Methylprednisolone	Methylprednisolone	22	20
Propranolol Hcl	Propranolol Hcl	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	13
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	19	suppressed
Glipizide	Glipizide	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Ramipril	Ramipril	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Prednisone	Prednisone	17	suppressed
Restasis	Cyclosporine	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Trulicity	Dulaglutide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Diazepam	Diazepam	13	suppressed
Estradiol	Estradiol	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Sodium Chloride	0.9 % Sodium Chloride	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Methimazole	Methimazole	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Zenpep	Lipase/Protease/Amylase	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Naratriptan Hcl	Naratriptan Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error